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SIX-YEAR RESULTS OF COLLAGEN MENISCUS IMPLANTS
EMPHASIZING LOCATION AND MENISCUS REMAINING
W.G. Rodkey1, K.K. Briggs1, J.R. Steadman2
1Steadman Hawkins Res. Fndn., Vail, CO; 2Steadman Hawkins
Clinic, Vail, CO
Purpose: Prospectively, we determined amount of meniscus loss
and anatomic location of Collagen Meniscus Implant (CMI) place-
ment after partial medial meniscectomy (PMM). At 1-year relook
we determined total meniscus tissue present based on surface
area coverage. We correlated percent of meniscus and anatomic
location of the original lesion with function and activity levels
6 years after CMI placement. We hypothesized that meniscus
amount and anatomic location would inﬂuence clinical function
and activity levels.
Methods: In a prospective randomized controlled multicenter clin-
ical trial (Level of Evidence I), 114 chronic patients (1 to 3 prior
PMM on the involved meniscus) 18 to 60 years old underwent
partial medial meniscectomy, and then randomly one group re-
ceived a CMI to ﬁll the meniscus defect. There were 68 PMM
only controls and 46 CMI patients. At index surgery, amount and
anatomic location of meniscus removed and CMI placement were
documented on a standard grid. Locations were categorized as
posterior (A), middle (B), or anterior (C) third. A 1-year relook
was done on CMI patients, and meniscus surface area coverage
was measured. Patients were followed clinically for a minimum of
two years and subjectively annually thereafter. Average follow-up
was 69 months (range, 24 to 92). All patients completed validated
questionnaires including Lysholm and Tegner scores to assess
function and activity.
Results: For CMI patients, 29 had lesions which included posterior
and middle thirds (AB), and 17 had lesions involving all three
zones (ABC). Lysholm scores were signiﬁcantly higher in patients
with AB lesions (81) compared to ABC lesions (71), p=0.046. AB
lesion patients also had signiﬁcantly higher Tegner index (0.70)
than ABC lesion patients (0.22), thus AB patients regained more
of their lost activity, p=0.049. Comparing all patients with ≥60%
meniscus surface area coverage, CMI patients had signiﬁcantly
higher Tegner index compared to controls (0.59 vs. 0.30), p=0.036.
No differences between treatment groups were seen in patients
with <60% meniscus surface area coverage. When comparing
24 month to ﬁnal follow-up values, controls had no change for
Lysholm (p=0.13) or Tegner (p=0.39) scores, but CMI patients
improved signiﬁcantly over time for both Lysholm (p=0.02) and
Tegner (p=0.04) scores.
Conclusions: Zones of meniscus involvement inﬂuenced clinical
outcomes at 6 years in CMI patients. Those whose lesions ex-
tended into all three zones did worse than those with lesions in
posterior and middle zones only. Patients with successful CMI
procedures yielding ≥60% meniscus surface area coverage were
signiﬁcantly better than PMM only controls for both clinical function
and activity levels. Noteworthy, CMI patients continue to improve
over time for clinical function and activity levels, but PMM controls
do not.
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ANATOMIC LOCATION OF PARTIAL MEDIAL
MENISCECTOMY CORRELATES WITH TWO-YEAR
FUNCTION AND ACTIVITY LEVELS
W.G. Rodkey1, K.K. Briggs1, J.R. Steadman2
1Steadman Hawkins Res. Fndn., Vail, CO; 2Steadman Hawkins
Clinic, Vail, CO
Purpose: Prospectively, we determined the anatomic loca-
tion of partial medial meniscectomy and then correlated the
anatomic location with function and activity levels two years post-
meniscectomy. We hypothesized that loss of the posterior third of
the medial meniscus would result in more compromised clinical
function and activity levels than loss of the middle or anterior third.
Methods: In a prospective randomized controlled multicenter clin-
ical trial (Level of Evidence I), 120 patients (18 to 60 years)
underwent partial medial meniscectomy and served as controls.
There were 74 acute (no prior meniscus surgery) and 46 chronic
(1 to 3 prior partial meniscectomies on the involved meniscus)
patients. At index surgery, the anatomic location of meniscus
removed was documented on a standard grid. Locations were
categorized as posterior, middle, or anterior third. Patients were
followed clinically for a minimum of two years after meniscectomy.
All patients completed validated questionnaires including Lysholm
and Tegner scores to assess function and activity.
Results: Seventeen (17) patients had isolated posterior third
meniscectomies, 83 had combined posterior/middle thirds, 10 had
isolated anterior, and 10 had combined anterior/middle/posterior
thirds partial meniscectomies. Patients with isolated posterior third
meniscectomies had signiﬁcantly lower Lysholm scores (78) com-
pared to all other patients (88) (p=0.01) and also had signiﬁcantly
lower Tegner scores (3.5) compared to all other patients (4.5)
(p=0.03) at a minimum of two years after the index partial menis-
cectomy. Based on actual measurements, the isolated posterior
third meniscectomy group had an average of 41% meniscus re-
moved, well below the 50% loss threshold level that has been
previously reported as a predictor of decreased function and ac-
tivity levels.
Conclusions: Function and activity levels were signiﬁcantly de-
creased two years after surgery in patients who had isolated
posterior third medial meniscectomies compared to all other pa-
tients with meniscus loss in other anatomic locations of the medial
meniscus. This decrement of function and activity occurred even
though less than 50% of the meniscus was removed. This study
conﬁrms the importance of preserving the posterior portion of the
meniscus. It also supports the potential positive beneﬁts that may
be achieved by replacing or regrowing lost meniscus tissue. Our
hypothesis was afﬁrmed.
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EVALUATIONS OF AVASCULAR MENISCAL REPAIR WITH A
NOVEL CONDUIT MANUFACTURED FROM VARIOUS
BIOABSORBABLE MATERIALS
M. Long1, F. Proch2, R. Zhang1, M.F. Koff3, L. Foo3,
J. Campbell2, H. Potter3, H. Schwartz2
1Stryker Joint Preservation, Mahwah, NJ; 2Schwartz BioMed.,
Fort Wayne, IN; 3Hosp. for Special Surgery, New York, NY
Purpose: Meniscus repair is dependent on the initial mechanical
ﬁxation, stability of the tear and the regional biological repair mech-
anisms largely dependent on establishing vascularity at the tear
site. The placement of a conduit (BioDuct®) between the vascular
bed of the meniscus or the vascularized synovium/capsule has
shown promise in repairing tears in less vascularized zones. This
study aimed to compare various bioabsorbable polymer materials
to assess i) the biomechanical and degradation characteristics
after in vitro simulation and ii) the biomechanical, histological and
MRI characteristics of repair tissue using the canine avascular tear
model.
Methods: The study devices were manufactured from bioab-
sorbable PLLA/PGA (%/%) materials: 100/0, 85/15, 50/50, 10/90,
and sterilized via gamma irradiation. In vitro degradation was per-
formed over 12 weeks according to ASTM standard F-1635-04a,
with characterization by weight loss and mechanical properties
(n=6) and inherent viscosity measurements (n=3). In the in vivo
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adult dog model, two 5-mm longitudinal tears were created in the
avascular portion of the medial meniscus. Each tear was treated
with one BioDuct® implant placed at the tear site (n=10), fol-
lowed by suture repair. After 16 weeks, both knees were assessed
for gross pathology, articular cartilage damage (India ink stain-
ing), and repair tissue appearance. Limbs were processed for 3T
MRI and histologic examination (n=4) or biomechanical evaluation
(n=6). MRI evaluation utilized a water-sensitive, moderate echo
time fast spin echo protocol previously applied clinically, with a
resolution of 175 μm by 187.5 μm by 1.2 mm. Meniscal healing
was made based on the presence or absence of ﬂuid inhibition
into the repair site as well as any discernible fragmentation.
Results: In vitro, the PLLA and 85/15 materials did not lose
mass throughout the study. The 50/50 and 10/90 samples began
to lose mass after 3 and 1 week, respectively and were almost
completely degraded by 7 weeks. The inherent viscosity of the
materials decreased more rapidly with increasing PGA content.
The 3-point bend and crush strength properties of the implants
were found to decrease with time, with the exception of PLLA.
Figure 1. Biomechanical strength of repaired tear.
In vivo, all of the BioDuct® implant groups provided function-
ally healed avascular meniscal tissue in the dogs, independent of
bioabsorbable polymer tested. Tear strengths of the repaired avas-
cular tissue acquired 35-58% of contralateral, unoperated tissue
(Fig. 1). Histological analysis showed evidence of tissue ingrowth
and guided tissue engineering through the lumen of the conduit
(Fig. 2). MRI analyses conﬁrmed healing in 6 out of 8 anterior
repairs and 7 out of 8 posterior repairs where the conduit was
used (Fig. 3). Mild to moderate synovitis and chondral defects not
necessarily associated with the use of the implant were observed
with MRI; however, these defects were not apparent at gross
necropsy via India ink staining.
Figure 2. Denovo tissue in BioDuct conduit
lumen.
Figure 3. Sagittal fast spin echo
MR demonstrates lack of ﬂuid
inhibition, suggesting healing.
Conclusions: This study demonstrated the success of BioDuct®
repair in enabling healing of avascular tear in a dog meniscus,
independent of the PLA/PGA materials tested.
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SPECIFIC FACTORS ARE ASSOCIATED WITH FAILURE OF
MENISCUS SUTURE REPAIR
W.G. Rodkey1, K.K. Briggs1, J.R. Steadman2
1Steadman Hawkins Res. Fndn., Vail, CO; 2Steadman Hawkins
Clinic, Vail, CO
Purpose: Meniscus repairs with sutures have become more com-
mon as the importance of preserving the meniscus has been
established. Studies have shown a high rate of repeat surgery,
but it is unclear what factors contribute to failure. The purpose
of this study was to determine what factors lead to failure of su-
ture meniscus repair. Failure was operationally deﬁned as repeat
surgery on the meniscus within 2 years of the repair.
Methods: Two hundred eighty-three (283) meniscus suture re-
pairs were performed by a single surgeon. The average patient
age was 31 years (range, 18 to 71). There were 177 males
and 106 females. All repairs were completed with an inside-out
suture technique. One hundred thirty-seven (137) had an ACL re-
construction and meniscus repair (93 concurrent reconstructions
and 44 two-staged ACL reconstructions). One hundred eighty-one
(181) medial menisci and 102 lateral menisci were repaired. Of the
medial repairs, 80% were in the posterior third of the meniscus,
11% in the middle third, 1% in the anterior third, and 8% extended
to all areas of the meniscus. Of the lateral meniscus repairs, 49%
were in the posterior third, 26% in the middle third, 22% in the
anterior third, and 3% extended to all areas.
Results: Twenty-eight (28) patients (10%) had required repeat
surgery on the repaired meniscus within the ﬁrst 2 years and were
considered failures. The average time to repeat meniscus surgery
was 12 months (range, 2.5 to 24 months).There were no differ-
ences based on age, gender or location. Thirteen percent (13%)
of medial repairs and 4% of lateral repairs failed (p=0.012). Me-
dial meniscus repairs failed signiﬁcantly earlier (5.6 months) than
lateral meniscus repairs (12.9 months) (p=0.001). For patients
who had ACL reconstruction and meniscus repair, factors associ-
ated with failure included age (failed age=22; non-failure age=29;
p=0.013), and concurrent ACL reconstruction (two-staged repair
failures=2%; concurrent repair failures=11%; p=0.04).
Conclusions: Failure of suture repair of the meniscus within the
ﬁrst two years following index repair is more likely to occur in
medial meniscus repairs and in young patients who had a repair
and concurrent ACL reconstruction.
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USING A CULTURE MODEL OF HUMAN TENOCYTES TO
INVESTIGATE THE EFFECTIVENESS OF TENDOACTIVE®
FOR THE PROPHYLAXIS AND TREATMENT OF
TENDINOPATHIES
A. Torrent1, R. Ruhí1, M. Cid2, C. Csaki3, M. Shakibaei3
1R&D Joint Care Dept., BIOIBERICA S.A., Palafolls (Barcelona),
Spain; 2Sport Nutrition Dept., BIOIBERICA S.A., Barcelona,
Spain; 3Musculoskeletal Res. Group, Inst. of Anatomy,
Ludwig-Maximilian-Univ. Munich, Munich, Germany
Purpose: Tendons have a limited capacity for self-repair due to low
cell density and little mitotic activity. Pro-inﬂammatory cytokines
such as interleukin-1β (IL-1β) have been identiﬁed as the main
initiators of tendinopathies, stimulating inﬂammation, apoptosis
and extracellular matrix (ECM) degradation. The aim of this study
was to evaluate the potential of Tendoactive®, a nutraceutical
formulation that contains mucopolysaccharides, hydrolyzed type I
collagen and vitamin C, in an in vitro model of tendon inﬂammation.
Methods: In monolayer cultures, primary human tenocytes were
either treated with Tendoactive®, non-stimulated or stimulated with
